Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
5.68
-0.01 (-0.18%)
Jan 26, 2026, 4:00 PM EST - Market closed
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $38.33 million as of January 26, 2026. Its market cap has decreased by -44.81% in one year.
Market Cap
38.33M
Enterprise Value
-25.19M
1-Year Change
-44.81%
Ranking
Category
Stock Price
$5.68
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $38.33M, a decrease of -96.42%. That is a compound annual growth rate of -44.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 38.37M | 0.24% |
| Dec 31, 2025 | 38.27M | -45.94% |
| Dec 31, 2024 | 70.80M | -35.06% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actinium Pharmaceuticals | 40.55M |
| TuHURA Biosciences | 40.54M |
| Passage Bio | 39.99M |
| OnKure Therapeutics | 39.70M |
| Exicure | 39.26M |
| Lantern Pharma | 38.70M |
| Apollomics | 38.63M |
| Reviva Pharmaceuticals Holdings | 38.09M |